Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia
Benshang Li, Samuel W. Brady, Xiaotu Ma, et al.
Blood (2019) Vol. 135, Iss. 1, pp. 41-55
Open Access | Times Cited: 235

Showing 1-25 of 235 citing articles:

Pediatric acute lymphoblastic leukemia
Hiroto Inaba, Charles G. Mullighan
Haematologica (2020) Vol. 105, Iss. 11, pp. 2524-2539
Open Access | Times Cited: 534
The genomic landscape of pediatric acute lymphoblastic leukemia
Samuel W. Brady, Kathryn G. Roberts, Zhaohui Gu, et al.
Nature Genetics (2022) Vol. 54, Iss. 9, pp. 1376-1389
Open Access | Times Cited: 234
Substitution mutational signatures in whole-genome–sequenced cancers in the UK population
Andrea Degasperi, Xueqing Zou, Tauanne Dias Amarante, et al.
Science (2022) Vol. 376, Iss. 6591
Open Access | Times Cited: 190
St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem
Clay McLeod, Alexander M. Gout, Xin Zhou, et al.
Cancer Discovery (2021) Vol. 11, Iss. 5, pp. 1082-1099
Open Access | Times Cited: 169
Accurate genomic variant detection in single cells with primary template-directed amplification
Veronica Gonzalez-Pena, Sivaraman Natarajan, Yuntao Xia, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 24
Open Access | Times Cited: 111
Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations
Linea Natalie Toksvang, Shawn H. R. Lee, Jun J. Yang, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1749-1758
Open Access | Times Cited: 85
Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers
Venu Thatikonda, S. M. Ashiqul Islam, Robert Autry, et al.
Nature Cancer (2023) Vol. 4, Iss. 2, pp. 276-289
Open Access | Times Cited: 43
Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia
Shangyu Hou, Junya Liu, Yinghui Zhu
Cell investigation. (2025) Vol. 1, Iss. 1, pp. 100007-100007
Open Access | Times Cited: 2
T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies
Valentina Cordoʹ, Jordy C.G. van der Zwet, Kirsten Canté-Barrett, et al.
Blood Cancer Discovery (2020) Vol. 2, Iss. 1, pp. 19-31
Open Access | Times Cited: 102
The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities
Thai Hoa Tran, Stephen P. Hunger
Seminars in Cancer Biology (2020) Vol. 84, pp. 144-152
Closed Access | Times Cited: 92
Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing
Scott Newman, Joy Nakitandwe, Chimene Kesserwan, et al.
Cancer Discovery (2021) Vol. 11, Iss. 12, pp. 3008-3027
Open Access | Times Cited: 84
Therapeutic and prognostic insights from the analysis of cancer mutational signatures
Samuel W. Brady, Alexander M. Gout, Jinghui Zhang
Trends in Genetics (2021) Vol. 38, Iss. 2, pp. 194-208
Open Access | Times Cited: 66
Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia
Masayuki Umeda, Jing Ma, Benjamin J. Huang, et al.
Blood Cancer Discovery (2022) Vol. 3, Iss. 3, pp. 194-207
Open Access | Times Cited: 63
Untangling the web of intratumour heterogeneity
Zheqi Li, Marco Seehawer, Kornélia Polyák
Nature Cell Biology (2022) Vol. 24, Iss. 8, pp. 1192-1201
Closed Access | Times Cited: 58
The role of DNA mismatch repair in immunotherapy of human cancer
Yuchen He, Luyuan Zhang, Ruoyu Zhou, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 2821-2832
Open Access | Times Cited: 43
Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia
Zhenhua Li, Ti‐Cheng Chang, Jacob J. Junco, et al.
Blood (2023)
Open Access | Times Cited: 32
SUMOylation inhibition potentiates the glucocorticoid receptor to program growth arrest of acute lymphoblastic leukemia cells
Emma Valima, Vera Varis, Kseniia Bureiko, et al.
Oncogene (2025)
Open Access | Times Cited: 1
MOLECULAR PROFILING REVEALS NOVEL GENE FUSIONS AND GENETIC MARKERS FOR REFINED PATIENT STRATIFICATION IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
Borbála Péterffy, Szilvia Krizsán, Bálint Egyed, et al.
Modern Pathology (2025), pp. 100741-100741
Open Access | Times Cited: 1
Pathogenesis of pediatric B‑cell acute lymphoblastic leukemia: Molecular pathways and disease treatments (Review)
Fang‐Liang Huang, En‐Chih Liao, Chia‐Ling Li, et al.
Oncology Letters (2020) Vol. 20, Iss. 1, pp. 448-454
Open Access | Times Cited: 65
Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL
Praveen Anand, Amy Guillaumet-Adkins, Valeriya Dimitrova, et al.
Blood (2020) Vol. 137, Iss. 18, pp. 2463-2480
Open Access | Times Cited: 61
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia
Koichi Oshima, Junfei Zhao, Pablo Pérez‐Durán, et al.
Nature Cancer (2020) Vol. 1, Iss. 11, pp. 1113-1127
Open Access | Times Cited: 57
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
Jason R. Schwartz, Jing Ma, Jennifer L. Kamens, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
Miguel Olivas-Aguirre, Liliana Torres-López, Igor Pottosin, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 41
Epigenetic enzyme mutations as mediators of anti-cancer drug resistance
Sihong Chen, Yingxi Zhao, Shougeng Liu, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100821-100821
Closed Access | Times Cited: 34
Elucidating minimal residual disease of paediatric B-cell acute lymphoblastic leukaemia by single-cell analysis
Yingchi Zhang, Shicheng Wang, Jingliao Zhang, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 2, pp. 242-252
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top